Zippin Pharma Private Limited

Zippin Pharma Private Limited - healthcare in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U74999MH2019PTC323390 Incorporated 29 March 2019 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2025
₹194.99 Cr
▲ 19.27% YoY
Net profit · FY 2025
₹2.72 Cr
Net margin 1.4%
EBITDA · FY 2025
₹4.8 Cr
EBITDA margin 2.5%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
13
Provident fund records
Directors on board
2
As per MCA filings

About Zippin Pharma Private Limited

Data last updated:

Zippin Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 29 March 2019 and has been in existence for over 7 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2019PTC323390. Its GSTIN is 27AABCZ3505H1ZE (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajendra Chandrama Singh and Shyam Sunder Tulsianey.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹194.99 Cr. For the same year it recorded a net profit of ₹2.72 Cr (net margin 1.4%) and EBITDA of ₹4.8 Cr (EBITDA margin 2.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 24% over five years.

The company has about 13 employees on its provident fund (EPFO) records.

Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it; 3 cases are pending. The company has 1 deal on record (1 secondary share transfer); the latest was in April 2019. Its 3 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading) are compared by revenue, 2 larger and 1 smaller; the largest is Thulasi Pharmacies India Private Limited with revenue of ₹202.66 Cr. The company has 6 MSME Form 1 returns on record between 2020 and 2023, listing 23 overdue payments to 5 micro and small suppliers.

Company details

CIN U74999MH2019PTC323390
Registration Number 323390
Incorporation Date 29 March 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025

Contact details

Zippin Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    91 Springboard Gate No 2 Godrej Industrial Estate, Lbs Marg Vikhroli (West), Mumbai, Maharashtra, India – 400079
  • Industry
    Healthcare, Medical Equipment Retail & Distribution

To see the full contact details of Zippin Pharma Private Limited, buy the company report.

Comprehensive company report
Zippin Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Zippin Pharma is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Zippin Pharma Private Limited, buy the company report.

Financials of Zippin Pharma Private Limited

FY 2025 filings available

Zippin Pharma Private Limited reported revenue of ₹194.99 Cr for FY 2025.

Revenue · FY 2025
₹194.99 Cr
Net profit · FY 2025
₹2.72 Cr margin 1.4%
EBITDA · FY 2025
₹4.8 Cr margin 2.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▲ 7%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 33%
5 years · compounded
▲ 23%

Revenue has grown at a compounded annual rate (CAGR) of 24% over five years. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹4.8 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.72 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.5%
Net Profit Margin1.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Zippin Pharma Private Limited, buy the company report.

Board of directors of Zippin Pharma Private Limited

Zippin Pharma has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajendra Chandrama SinghDirector29 Mar 20197 Years 6 MonthsCurrent
Shyam Sunder TulsianeyDirector29 Mar 20197 Years 6 MonthsCurrent

Peer comparison

Zippin Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Thulasi Pharmacies India Private Limited₹202.66 Cr (FY 2025)8.0%Coimbatore, Tamil Nadu, India
Pers Enterprises Private Limited₹197.75 Cr (FY 2025)13.0%Chennai, Tamil Nadu, India
Zippin Pharma Private Limitedthis company₹194.99 Cr (FY 2025)₹2.72 Cr1.4%13Mumbai, Maharashtra, India
Yogiram Distributors Private Limited₹193.7 Cr (FY 2025)44.0%Cuddalore, Tamil Nadu, India

To see the full peer comparison of Zippin Pharma Private Limited, buy the company report.

Auditor

Zippin Pharma Private Limited is audited by Walker Chandiok & Co LLP for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Walker Chandiok & Co LLPFY 2023001076N/N500013

Shareholding

The shareholding of Zippin Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Zippin Pharma Private Limited, buy the company report.

Deals & funding

Zippin Pharma Private Limited has 1 deal on record (1 secondary share transfer); the latest was in April 2019.

Total deals
1
Secondary share transfer
1

Deals on record (1 of 1)

WhenDealAmountParties
Apr 2019Secondary share transferUndisclosedBuyer: an individual
Seller: an individual

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Zippin Pharma Private Limited has 6 MSME Form 1 returns on record between 2020 and 2023, listing 23 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 5)

SupplierAmount dueDue sinceReported on
Dunzo Merchant Services Private Limited
Dubaria Computers Private Limited
an individual supplier
L K Nakashe Consultants Private Limited
Impact Graphics

To see the full MSME payment records of Zippin Pharma Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Zippin Pharma Private Limited has a workforce of 13 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.

Employee count
13
Active EPFO establishments
1
Employee growth
-43.48%

GST

Zippin Pharma has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AABCZ3505H1ZEMaharashtraActive29 Mar 2019
24AABCZ3505H1ZKGujaratActive19 Nov 2021

To see the full GST registrations and return filing status of Zippin Pharma Private Limited, buy the company report.

Recent activity

Zippin Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Rajendra Chandrama Singh was appointed as Director on 29 Mar 2019.

AGM
Zippin Pharma Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Zippin Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Rajendra Chandrama Singh was appointed as Director.
Appointed
Shyam Sunder Tulsianey was appointed as Director.
Incorporation
29 Mar 2019
Zippin Pharma Private Limited was registered on 29 Mar 2019 with Roc Mumbai & aged 7 years 7 months as per MCA records.

News

Zeno Health acquires Tablt Pharmacy
04 Apr 2024 · Times Of India
Zeno Health Acquires Kolkata-based TabIt Pharmacy
04 Apr 2024 · bwdisrupt.businessworld

Frequently asked questions

Zippin Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 29 March 2019 (7+ years old) and is registered under CIN U74999MH2019PTC323390.

Zippin Pharma has 2 current directors:

The latest financial statements of Zippin Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 25 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Zippin Pharma is 27AABCZ3505H1ZE, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 24AABCZ3505H1ZK (Gujarat).

The CIN (Corporate Identification Number) of Zippin Pharma is U74999MH2019PTC323390. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Zippin Pharma has 13 court cases on record: 12 filed by the company and 1 filed against it. 3 are pending. Most are in the high courts.

Zippin Pharma was incorporated on 29 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.

Zippin Pharma has 1 deal on record (1 secondary share transfer); the latest was in April 2019.

The peers of Zippin Pharma by revenue are Thulasi Pharmacies India Private Limited, Pers Enterprises Private Limited, Yogiram Distributors Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (retail trading).

Rajendra Chandrama Singh was appointed as Director on 29 Mar 2019. Shyam Sunder Tulsianey was appointed as Director on 29 Mar 2019.

Zippin Pharma has 6 MSME Form 1 returns on record between 2020 and 2023, listing 23 overdue payments to 5 micro and small suppliers. The latest return was filed on 29 Aug 2023.

The registered office of Zippin Pharma is at 91 Springboard Gate No 2 Godrej Industrial Estate, Lbs Marg Vikhroli West, Mumbai, Maharashtra, India – 400079.